维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Sipponen T"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactofen'in 显示文摘	Sipponen T	2013	Dig Dis2013，31，34：	1
2	Fecal calprotectin,lactoferrin,and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease显示文摘	Sipponen T Savilahti E Karkkainen P		0，，10：	1
3	Comparison of nefopam and pethidine in postoperative pain显示文摘	Tigerstedt I Sipponen J Tammisto T	1977	Br J Anaesth1977，49，11：	1
4	Crohnrs disease activity assessed by fecal calprotectin and lactoferrin:cor- relation with Crohns disease activity index and endoscop- ic findings显示文摘	Sipponen T Savilahti E Kolho KL	2008	Inflamm Bowel Dis2008，14，1：	1
5	Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis:an observational case-control study显示文摘	Sipponen P Ranta P Helske T	2002	Scand J Gastroenterol2002，，7：	1
6	Correlation of faecal calprotectin and lactoferrln with an endoscopic score for Crohn's disease and histological findings显示文摘	Sipponen T Kirkkinen P Savilahti E	2008	Al- iment Pharmacol Ther2008，28，10：	1
7	IL-23/IL-17 immunity as a hallmark of Crohn' s disease 显示文摘	Hota V Klemetti P Sipponen T	2008	Inflamm Bowel Dis2008，14，9：	1
8	Crohn’s disease activity as-sessed by fecal caipeotectin and lactoferrin:correlation with Crohn’sdisease activity index and endoscropic findings显示文摘	Sipponen T Savilahti E Kolho KL	2008	Inflam BowelDis2008，14，1：	1
9	The GU-MACH study:the efface of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer显示文摘	Malfertheiner P Bayerdorffer E Diete U Gil J Lind T Misiuna P O'morain C Sipponen P Spiller RC Stesiewicz J Treichel H Ujszaszy L Unge P Zanten ST Zeijlon L	1999	Aliment Pharmacol Ther1999，13，6：	1
10	Mucosal heal- ing at 3 months predicts long-term endoscopic remission in anti- TNF-treated luminal Crohn'sdisease 显示文摘	af Bjorkesten CG Nieminen U Sipponen T	2013	Scand J Gastroenterol2013，48，5：	1
11	Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gasrhis: an observational ease-control study 显示文摘	Sipponen P Ranta P Helske T	2002	Scand ] Gastroenterol2002，37，7：	1
12	In crohn's disease, anti-TNF-alpha treatment changes the balance between mucosal IL-17, FOXP3, and CDg Cells 显示文摘	HOLTTA V SIPPONEN T WESTERHOLM -- ORMIO M	2012	ISRN Gastroenterol2012，75，3：	1
13	Diagnostics and prognostics of inflammatory bowel disease with fecal neutrophil-derived biomarkers calprotectin and lactoferrin显示文摘	Sipponen T	2013	Dig Dis2013，31，34：	1
14	IL-23/IL-17 im- munity as a hallmark of Crohn's disease显示文摘	Holtta V Klemetti P Sipponen T	2008	Inflamm Bowel Dis2008，14，9：	1
15	Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis:an observational case-control study 显示文摘	Sipponen P Ranta P Helske T	2002	Scand J Gastroenterol2002，，7：	1
16	Crohn's disease activity assessed by fecal calprotectin and lactoferrin:correlation with disease activity index and endoscopic fmdings显示文摘	Sipponen T Savilahti E Kolho KL	2008	Inflamm Bowel Dis2008，14，1：	1
17	Serum levels of amidatel gastrin-17 and pepsinogen I in atrophic gastri- tis:an observational lase-contyol study 显示文摘	Sipponen P Ranta P Helske T	2002	Scand J Gastroenteral2002，37，：	1
18	An 18-year follow-up study of chronic gastritis and Helicobacter pylori assosiation of CagA positive with development of atrophy and activity of gastritis 显示文摘	Maaroos HI Vorobjova T Sipponen P	1999	Scand J Gastroenterol1999，34，9：	1
19	Serum Levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis:an observational case-caontrol study显示文摘	SIPPONEN P RANATA P HELSKE T	2002	Scand J Gastroenterol2002，37，7：	1
20	Serum levels of amidated gas- trin-17 and pepsinogen I in atrophic gastritis: an observational case- control study 显示文摘	Sipponen P Ranta P Helske T	2002	Scand J Gastroenterol2002，37，7：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示